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Letter to the Editor — “Visual assessment for xanthochromia needs no
revisitation”
Sir, recently Linn et al. compared visual with spectrophotometric as-
sessment of xanthochromic cerebrospinal ﬂuid (CSF) and concluded that a
sample perceived as colourless is incompatible with the diagnosis of recent
subarachnoid haemorrhage (SAH) [1]. Six CSF samples spiked with bilirubin
and one normal CSF sample were assessed by 102 subjects visually. Spec-
trophotometry between 450–460 nm established extinctions from 0.01 to 0.09
in the six spiked samples.
The observations made by Linn et al. are valuable, albeit our interpreta-
tion of their results diﬀers from their own. We think that the study conﬁrms
that visual assessment of the CSF for low concentrations of bilirubin is in-
ferior to spectrophotometry. To illustrate this point we compare in Table 1
our own results contrasting visual with spectrophotometric detection of low
concentrations of bilirubin with those of Linn et al. [1, 2]. For this post–hoc
analysis, we have only included the observed frequencies of their samples
seen as “yellow” or as “colourless”. Samples for which no decision could be
made because the visual inspection was “doubtful” are not included. Clearly,
both sets of data demonstrate that human colour vision is less sensitive than
spectrophotometry for detecting small amounts of bilirubin from the CSF. It
would be interesting to analyse the original absorption spectra of the Linn
et al. [1] to determine whether their visual threshold (extinction of 0.06)
1corresponds to ours (excitation purity or saturation of about 2.4%) [2].
We would like to pose three additional questions: (1) Why was an ar-
bitrary cutoﬀ of 0.05 chosen as opposed to 0.023 which was the criterion
published by the same group previously [3]? (2) Why was a spectral band-
width (450–460 nm) selected for measuring an extinction as opposed to the
recommended absorbance at 476 nm [4]? (3) Given that the major “real
life” problem for visual assessment of CSF from a recent SAH is likely to
be contamination with blood (of red colour) [5], why was visual assessment
restricted to a sensitivity problem (i.e., detection of low concentrations of
bilirubin in an otherwise colourless sample)? If one extrapolates from pre-
vious data [3] such an analysis is more appropriate for CSF samples taken
quite some time after a SAH, rather than, as the authors intended, recently
following a SAH.
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